Corynebacterium parvum, BCG, OK-432およびLactobacillus caseiのマウス肝薬物代謝酵素と肝マクロファージの活性酸素生成能におよぼす影響
スポンサーリンク
概要
- 論文の詳細を見る
Influence and mechanisms of four immunostimulants, Maycobacterium bovis (BCG), Streptococcus preparation (OK-432), Corynebacterium parvum (C. parvum), Lactobacillus casei YIT 9018 (LC 9018) and Lactobacillus fermentum YIT 0159 (LF), which had no immuno stimulating activity, on the activity of hepatic drug-metabolizing enzyme and on the activity of glucose-6-phosphate dehydrogenase (G6PD) and on the oxygen radical production by fixed macrophages in the liver of BALB/c mouse were studied. The levels of cytochrome P-450 and the activities of aminopyrine demethylase (APD), nicotinamide adenine dinucleotide phosphate-cytocrome c (NADPH-cytochrome c) reductase significantly decreased after the i. v. injection of BCG, LC 9018,OK-432,C. parvum and LF compared to the saline-injected control mice, but the level of cytochrome b_5 was not altered with these treatments. On the other hand, G6PD activity in the liver more remarkably increased with these immunostimulants than the saline i. v. injected mice, and oxygen radical production by fixed macrophages in the liver significantly increased after i. v. injection of LC 9018 and C. parvum. It was suggested that the ability to reduce the enzyme activities of APD and NADPH-cytochrome c reductase and the levels of cytochrome P-450 and cytochrome b_5 of the liver has no correlation with tumoricidal and bactericidal activity of these bacterial immunostimulants.
- 公益社団法人日本薬学会の論文
- 1984-04-25
著者
-
横倉 輝男
ヤクルト中央研究所
-
横倉 輝雄
Yakult Institute for Microbiological Research
-
橋本 秀介
(株)ヤクルト本社中央研究所
-
横倉 輝男
(株)ヤクルト本社中央研究所
-
務台 方彦
(株)ヤクルト本社中央研究所
-
橋本 秀介
ヤクルト本社 中研
関連論文
- 乳酸桿菌の自然免疫系賦活作用の解析
- LACTOBACILLUS CACEIのラット膀胱発癌に対する影響
- Involvement of Protease Inhibitors in Staphylokinase-Induced Fibrin-Specific Fibrinolysis
- Fibrin-Specific Fibrinolysis Induced by Recombinant Staphylokinase
- Measurement of Staphylokinase by Enzyme-Linked Immunosorbent Assay Using Monoclonal Antibodies
- 453 Streptomyces sp. C-51株由来のコラゲナーゼの生産条件および性質について
- Chemical Modification of Antitumor Alkaloids, 20(S)-Camptothecin and 7-Ethylcamptothecin : Reaction of the E-Lactone Ring Portion with Hydrazine Hydrate
- カンプトテシン誘導体の合成および抗腫瘍活性 : 7-エチル-10-ヒドロキシカンプトテシンの水溶性カルバメート誘導体(発表論文抄録(1991年))
- Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives : Carbamate-Linked, Water-Soluble Derivaties of 7-Ethyl-10-hydroxycamptothecin
- モズクフコイダンおよびウロン酸含有多糖の蛍光標識法およびHPLC分析法の検討
- モズク由来フコイダンの抗潰瘍効果について : 生体高分子・脂質
- モズク由来フコイダンの構造とHelicobactor pyloriに対する定着阻害作用について : 生体高分子・脂質
- Anti-ulcer Effects of Lactic Acid Bacteria and Their Cell Wall Polysaccharides
- Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives. A-Ring-Substituted 7-Ethylcamptothecins and Their E-Ring-Modified Water-Soluble Derivatives
- Synthesis and Antiumor Activity of 20(S)-Camptothecin Derivatives : A-Ring Modified and 7,10-Disubstituted Camptothecins
- Chemical Modification of an Antitumor Alkaloid, 20(S)-Camptothecin : E-Lactone Ring-Modified Water-Soluble Derivatives of 7-Ethylcamptothecin
- Determination of Self-Association of Irinotecan Hydrochloride (CPT-11) in Aqueous Solution
- Chemical Modification of an Antitumor Alkaloid, 20(S)-Camptothecin : Glycosides, Phosphates and Sulfates of 7-Ethyl 10-hydroxycamptothecin
- Chemical Modification of an Antitumor Alkaloid Camprothecin : Synthesis and Antitumor Activity of 7-C-Substituted Camptothecins
- Tyrosinase Inhibitors from Crude Drugs
- 乳酸菌による予防医学をめざして (あゆみ 食から薬へ)
- アセクロフェナクの細胞内ターゲット抗炎症効果
- Corynebacterium parvum, BCG, OK-432およびLactobacillus caseiのマウス肝薬物代謝酵素と肝マクロファージの活性酸素生成能におよぼす影響
- 乳酸菌の抗腫瘍効果
- Target anti-inflammatory effects in aceclofecna cells.
- Chemotherapy of malignant tumor viewed from pharmacodynamics of antitumor medicines.5.Pharmacokinetics of topoisomerase inhibitor and antitumor effect.